Thieno[2,3-b]pyridine compounds potently inhibit prostate cancer growth and motility - Alkheilewi, M A; Leach, D A; Mohr, A; Zwacka, R M; Laissue, P; Metodiev, M; Bevan, C L; Van Rensburg, M; Pilkington, L I; Barker, D; Reynisson, J; Brooke, G N (Endocrine oncology, 2025)
Keywords: multinucleation; prostate cancer; therapeutics; therapy resistance; prostate cancer; therapeutics; multinucleation; therapy resistance